S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Pacira Pharmaceuticals, Inc. (PCRX) to Contact the Firm|
|Pacira Pharmaceuticals, Inc. to Present at the Wedbush 2014 Life Sciences Management Access Conference|
|Pacira Pharmaceuticals, Inc. Reports Second Quarter 2014 Results: EXPAREL Revenue up 31% Over First Quarter|
|Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Pacira Pharmaceuticals, Inc. (2014/10/7)|
|Pacira Pharmaceuticals Announces Timing for Third Quarter 2014 Financial Results Webcast and Conference Call|
|SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Pacira Pharmaceuticals, Inc. To Contact Brower Piven Before The December 2, 2014 Lead Plaintiff Deadline In Class Action Lawsuit|
|Pacira Pharmaceuticals, Inc. Announces Receipt of FDA Warning Letter|
|Pacira Pharmaceuticals, Inc. Announces Additional Data Supporting Safety of EXPAREL® in Peripheral Nerve Block|
|Roy Jacobs & Associates Announces Investigation into Possible Wrongdoing at Pacira Pharmaceuticals, Inc. (PCRX) (2014/10/6)|
|INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Pacira Pharmaceuticals, Inc. (PCRX) To Contact The Firm|
Click above to view more mutual fund data and stats for pcrx - Pacira Pharmaceuticals Inc.